Study Stopped
Pending further safety information regarding polysaccharides and premature infants
A Multi-strain Synbiotic Versus a Multi-strain Probiotic in Premature Infants
A Randomized Controlled Trial on a Multi-strain Synbiotic vs. a Multi-strain Probiotic on Fecal Colonization in the Very Low Birth Weight Infant
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
The aims are to 1) compare two probiotic treatments (multi-strain synbiotic vs. multi-strain probiotic) on bifidobacteria fecal colonization counts at 1, 2, 3, and 4 weeks of life, 34 weeks corrected gestation age (CGA) ; 2) compare infants successfully colonized with probiotic organisms to infants not successfully colonized at 1, 2, 3, and 4 weeks of life, 34 weeks CGA on infant outcomes and on stress biomarker patterns at birth, day of life (DOL) 1, DOL 7; 3) determine long-term safety and outcomes of probiotic treatments at 6, 16, and 24 months CGA.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jun 2011
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 16, 2011
CompletedFirst Posted
Study publicly available on registry
April 19, 2011
CompletedStudy Start
First participant enrolled
June 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 16, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
June 16, 2011
CompletedAugust 14, 2023
August 1, 2023
15 days
March 16, 2011
August 10, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Comparing a multi-strain synbiotic vs. a multi-strain probiotic on mean bifidobacteria fecal colonization counts
Infants will be given the synbiotic or probiotic supplementation within the first week of life (upon inititation of enteral feedings) until approximately 34 weeks corrected gestational age.
1,2, 3, 4 and 34 weeks of age
Secondary Outcomes (5)
Compare the difference between two groups (multi-strain synbiotic vs. multi-strain probiotic) on demographic data and selected standard clinical infant outcomes.
From birth to NICU discharge (average 36 weeks corrected gestational age)
Compare the difference between infants successfully colonized with probiotic organisms (>10^2 colonies on a 10^4-fold dilution plate)to infants not successfully colonized on demographics and selected standard clinical outcomes
1 week of life to NICU discharge
Compare infants successfully colonized with probiotic organisms(>10^2 colonies on a 10^4-fold dilution plate) to infants not successfully colonized on stress biomarker levels
day of life 1 to day of life 7
Compare trends of stress biomarker levels in relation to demographics and selected standard infant outcomes
day of life 1 to day of life 7
Compare the difference between the two probiotic treatment groups (multi-strain synbiotic vs. multi-strain probiotic) on longitudinal neurodevelopmental outcomes.
6, 16 & 24 months corrected gestational age.
Study Arms (2)
Multi-strain Synbiotic
EXPERIMENTALMulti-strain probiotic with prebiotics
Multi-strain Probiotic
ACTIVE COMPARATORMulti-strain Probiotic without prebiotics.
Interventions
Multi-strain Synbiotic: 1.5 billion CFU of Lactobacillus acidophilus, Bifidobacterium bifidum,and Bifidobacterium lactis WITH galacto-oligosaccharide(GOS)/fructo-oligosaccharide (FOS) combination at 1g/dL (0.9g/dL GOS/ 0.1g/dL FOS)
Eligibility Criteria
You may qualify if:
- infants with a birth weight \< 1500g
- admission to NICU at The Nebraska Medical Center
You may not qualify if:
- infants who have congenital anomalies
- have a diagnosis of a congenital metabolic disease
- are made a ward of the State or
- are born to a mother \< 19 years of age
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Ann Anderson-Berry, MD
University of Nebraska
- STUDY CHAIR
Corrine K Hanson, PhD
UNMC
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 16, 2011
First Posted
April 19, 2011
Study Start
June 1, 2011
Primary Completion
June 16, 2011
Study Completion
June 16, 2011
Last Updated
August 14, 2023
Record last verified: 2023-08